Results 161 to 170 of about 5,663,878 (222)

Optimal Cut-Off Values of the Aldosterone-Renin Ratio in Different Age Groups for Primary Aldosteronism Screening. [PDF]

J Clin Hypertens (Greenwich)
Li D, Song H, Gong M, Yang M, Zhang Y, Jiang Y, Song W.   +6 more
europepmc   +1 more source

Assessing Primary Aldosteronism Screening Implementation and Interpretation in an Outpatient Internal Medicine Clinic: A Cohort Study. [PDF]

AACE Endocrinol Diabetes
Allen RB, Hui T, Tungate Lopez S, Komé AM, Yang A, Zink L, Espinosa LB.   +6 more
europepmc   +1 more source

Partially Successful Adrenal Vein Sampling With and Without Cross-Sectional Imaging in Primary Aldosteronism Subtyping. [PDF]

Hypertension
Vibhatavata P, Mermejo LM, Zhao L, Shields JJ, Turcu AF.   +4 more
europepmc   +1 more source

Myocardial fibrosis in primary aldosteronism. [PDF]

Front Endocrinol (Lausanne)
Chen YL, Chen CH, Ye XF, Xu JZ, Zhu LM, Xu TY, Li Y, Wang JG.   +7 more
europepmc   +1 more source

Retraction: The PI3K/AKT/mTOR Signaling Pathway Is Overactivated in Primary Aldosteronism. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging.

J Clin Endocrinol Metab
Teo AED, Tran HTN, Khoo CM, Osman I, Tong AK, Foo RSY, Puar TH.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Primary aldosteronism

BMJ, 2022
• Aldosterone excess can cause cardiovascular, cerebrovascular, and renal disease • Consider primary aldosteronism in patients with moderate to severe hypertension, resistant hypertension, hypertension with an adrenal mass, or hypokalaemia • A minority ...
Kay Weng Choy, Peter J. Fuller, Grant Russell, Qifu Li, M. Leenaerts, Jun Yang   +5 more
semanticscholar   +3 more sources